Condition: COVID-19 · Sponsor: Pfizer
The purpose of this clinical trial is to learn about the safety, pharmacokinetics (pharmacokinetics helps us understand how the drug is changed and eliminated from your body after you take it), and efficacy (how well a study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID-19). The study medicine will be given to patients under 18 years of age with COVID-19 that are not hospitalized but are at risk for severe disease.
This description comes directly from the study's public registry record.
Pfizer CT.gov Call Center · 1-800-718-1021 · ClinicalTrials.gov_Inquiries@pfizer.com
Always discuss trial participation with your own doctor first.
| Phoenix Children's Hospital | Phoenix, Arizona, United States | Active Not Recruiting |
| Children's Hospital Los Angeles | Los Angeles, California, United States | Active Not Recruiting |
| Kaiser Permanente | Los Angeles, California, United States | Active Not Recruiting |
| UCLA David Geffen School of Medicine | Los Angeles, California, United States | Not Yet Recruiting |
| UCLA | Los Angeles, California, United States | Not Yet Recruiting |
| Children's National Medical Center | Washington D.C., District of Columbia, United States | Active Not Recruiting |
| Life Spring Research Foundation | Miami, Florida, United States | Recruiting |
| Children's Healthcare of Atlanta - Arthur M. Blank Hospital | Atlanta, Georgia, United States | Recruiting |
| Rophe Adult and Pediatric Medicine/SKYCRNG | Union City, Georgia, United States | Terminated |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago, Illinois, United States | Active Not Recruiting |
| University of Chicago Medical Center | Chicago, Illinois, United States | Recruiting |
| Louisiana State University Health Sciences Shreveport | Shreveport, Louisiana, United States | Recruiting |
+ 61 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05261139